Abstract:Autosomal dominant optic atrophy is one of the most common inherited optic neuropathies. This disease is genetically heterogeneous, but most cases are due to pathogenic variants in the OPA1 gene: depending on the population studied, 32–90% of cases harbor pathogenic variants in this gene. The aim of this study was to provide a comprehensive overview of the entire spectrum of likely pathogenic variants in the OPA1 gene in a large cohort of patients. Over a period of 20 years, 755 unrelated probands with a diagnosis of bilateral optic atrophy were referred to our laboratory for molecular genetic investigation. Genetic testing of the OPA1 gene was initially performed by a combined analysis using either single-strand conformation polymorphism or denaturing high performance liquid chromatography followed by Sanger sequencing to validate aberrant bands or melting profiles. The presence of copy number variations was assessed using multiplex ligation-dependent probe amplification. Since 2012, genetic testing was based on next-generation sequencing platforms. Genetic screening of the OPA1 gene revealed putatively pathogenic variants in 278 unrelated probands which represent 36.8% of the entire cohort. A total of 156 unique variants were identified, 78% of which can be considered null alleles. Variant c.2708_2711del/p.(V903Gfs*3) was found to constitute 14% of all disease-causing alleles. Special emphasis was placed on the validation of splice variants either by analyzing cDNA derived from patients ́ blood samples or by heterologous splice assays using minigenes. Splicing analysis revealed different aberrant splicing events, including exon skipping, activation of exonic or intronic cryptic splice sites, and the inclusion of pseudoexons. Forty-eight variants that we identified were novel. Nine of them were classified as pathogenic, 34 as likely pathogenic and five as variant of uncertain significance. Our study adds a significant number of novel variants to the mutation spectrum of the OPA1 gene and will thereby facilitate genetic diagnostics of patients with suspected dominant optic atrophy.

A recurrent deletion mutation in OPA1 causes autosomal dominant optic atrophy in a Chinese family

A Novel OPA1 Mutation in a Chinese Family with Autosomal Dominant Optic Atrophy

The Molecular Pathogenesis of Autosomal Dominant Optic Atrophy

Identification of copy number variation in the gene for autosomal dominant optic atrophy, OPA1, in a Chinese pedigree.

A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family

Identification of Two Novel OPA1 Mutations in Chinese Families with Autosomal Dominant Optic Atrophy.

A novel OPA1 mutation responsible for autosomal dominant optic atrophy with high frequency hearing loss in a Chinese family.

A Novel Adoa-Associated Opa1 Mutation Alters the Mitochondrial Function, Membrane Potential, Ros Production and Apoptosis

Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.

The G401D Mutation of OPA1 Causes Autosomal Dominant Optic Atrophy and Hearing Loss in a Chinese Family.

Optic Atrophy and Sensorineural Hearing Loss in a Family Caused by an R445H OPA1 Mutation.

Targeted next-generation sequencing extends the mutational spectrums for OPA1 mutations in Chinese families with optic atrophy.

The OPA1 Gene Mutations Are Frequent in Han Chinese Patients with Suspected Optic Neuropathy

Very High Penetrance and Occurrence of Leber’s Hereditary Optic Neuropathy in a Large Han Chinese Pedigree Carrying the ND4 G11778A Mutation

Mutation of CRYAB Encoding a Conserved Mitochondrial Chaperone and Anti-Apoptotic Protein Causes Hereditary Optic Atrophy.

Leber's Hereditary Optic Neuropathy is Associated with the Mitochondrial G11696A Mutation in Two Chinese Families

Modeling Autosomal Dominant Optic Atrophy Using Induced Pluripotent Stem Cells and Identifying Potential Therapeutic Targets.

Clinical and Molecular Genetic Researches of a Family with Leber's Hereditary Optic Neuropathy

Pathogenicity Evaluation and the Genotype–phenotype Analysis of OPA1 Variants

Processing of OPA1 with a novel N-terminal mutation in patients with autosomal dominant optic atrophy: Escape from nonsense-mediated decay

Mutation spectrum of the OPA1 gene in a large cohort of patients with suspected dominant optic atrophy: Identification and classification of 48 novel variants